A detailed history of Deutsche Bank Ag\ transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 38,692 shares of ORIC stock, worth $297,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,692
Previous 29,361 31.78%
Holding current value
$297,154
Previous $207,000 91.3%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.52 - $11.9 $70,169 - $111,038
9,331 Added 31.78%
38,692 $396,000
Q2 2024

Aug 14, 2024

BUY
$6.63 - $12.93 $26,758 - $52,185
4,036 Added 15.94%
29,361 $207,000
Q1 2024

May 15, 2024

BUY
$8.04 - $16.03 $4,413 - $8,800
549 Added 2.22%
25,325 $348,000
Q4 2023

Feb 14, 2024

SELL
$5.41 - $9.43 $5,231 - $9,118
-967 Reduced 3.76%
24,776 $227,000
Q3 2023

Nov 09, 2023

BUY
$6.05 - $9.28 $23,038 - $35,338
3,808 Added 17.36%
25,743 $155,000
Q2 2023

Aug 14, 2023

SELL
$4.95 - $8.4 $15,998 - $27,148
-3,232 Reduced 12.84%
21,935 $170,000
Q3 2022

Nov 14, 2022

SELL
$3.15 - $5.24 $31,824 - $52,939
-10,103 Reduced 28.64%
25,167 $81,000
Q2 2022

Aug 11, 2022

BUY
$2.7 - $7.07 $48,292 - $126,454
17,886 Added 102.89%
35,270 $158,000
Q1 2022

May 13, 2022

SELL
$4.54 - $16.1 $9,252 - $32,811
-2,038 Reduced 10.49%
17,384 $93,000
Q4 2021

Feb 11, 2022

SELL
$12.01 - $20.3 $29,808 - $50,384
-2,482 Reduced 11.33%
19,422 $285,000
Q3 2021

Nov 04, 2021

BUY
$15.9 - $25.22 $26,902 - $42,672
1,692 Added 8.37%
21,904 $458,000
Q2 2021

Aug 11, 2021

BUY
$17.37 - $25.34 $61,298 - $89,424
3,529 Added 21.15%
20,212 $358,000
Q1 2021

May 13, 2021

BUY
$23.67 - $36.85 $3,242 - $5,048
137 Added 0.83%
16,683 $408,000
Q4 2020

Feb 16, 2021

BUY
$20.32 - $39.8 $237,317 - $464,824
11,679 Added 239.96%
16,546 $560,000
Q3 2020

Nov 12, 2020

BUY
$19.5 - $31.26 $8,229 - $13,191
422 Added 9.49%
4,867 $122,000
Q2 2020

Aug 13, 2020

BUY
$25.68 - $38.12 $114,147 - $169,443
4,445 New
4,445 $150,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $304M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.